Diabetic Microvascular Complications News

• Oculis' Eye Drug Meets Main Goal in Study Oculis Holding said on Monday its drug to treat a type of eye disorder met its main goal in a late-stage study, sending its shares up about 15% in premarket trading.
  Reuters Health Information, May 22, 2023
• Beta Blocker Gel Shows Promise for Diabetic Foot Ulcers A novel topical treatment appears to improve healing in patients with diabetic foot ulcers, suggest results from a phase 3 trial, although experts warn the results need confirming in further studies.
  Medscape Medical News, May 23, 2023
• ARVO 2023 Foot Ulcers Red Flag for Eye Disease in Diabetes The presence of diabetic foot ulcers may impede the care of retinopathy, researchers have found.
  Medscape Medical News, May 15, 2023
• ARVO 2023 Early Anti-VEGF Isn't Worth Cost in Diabetic Retinopathy A drug tested on patients with nonproliferative diabetic retinopathy did not improve vision outcomes.
  Medscape Medical News, April 25, 2023
• Smoking Cessation Has Many Benefits in Diabetes In addition to a slight and temporary risk for blood sugar imbalance, smoking cessation is associated with reduced risks for all-cause mortality and for macro- and microangiopathic complications.
  Medscape Medical News, April 25, 2023
• Pricey Diabetic Foot Ulcer Products Can't Beat Standard Care Diabetic foot ulcer healing occurred at the same rate with standard wound care, standard care plus acellular matrix, or standard care plus cellular matrix in a randomized study with 117 patients.
  First Look, April 21, 2023
• Strong Link Between Smoking and Diabetes Without exception, epidemiologic studies point toward a link between active and, to a lesser extent, passive smoking and the risk of developing type 2 diabetes.
  Medscape Medical News, April 18, 2023
• AAN 2023 Spinal Cord Stimulation May Help Diabetic Neuropathy The data represent the longest follow-up available for spinal cord stimulation at a frequency higher than 60 Hz, which was the frequency initially approved by the FDA.
  MDedge News, April 14, 2023
• Alarm Bells Ring for Eye Issues in Kids With Type 2 Diabetes Annual screening with fundus photography could allow for early detection and treatment of diabetic retinopathy in children diagnosed with type 2 diabetes.
  Medscape Medical News, March 23, 2023
• The Multidisciplinary Team Is Key in Treating Diabetic Foot "There's no such thing as a superspecialist who's able to handle all aspects related to the treatment of patients with diabetic foot," said one surgeon.
  Medscape Medical News, March 14, 2023
• Aflibercept Not for Prevention in Early Diabetic Retinopathy 'Preventive treatment with anti-VEGF [such as aflibercept] for eyes with nonproliferative diabetic retinopathy generally is not a strategy that is warranted,' says study investigator.
  Medscape Medical News, February 09, 2023
• Alert FDA Clears Spinal Cord Stimulator for Diabetic Neuropathy The Food and Drug Administration has approved Abbott's Proclaim XR spinal cord stimulation system for the treatment of diabetic peripheral neuropathy, the company announced.
  Medscape Medical News, January 26, 2023
• Eye Check Important Before Starting Semaglutide for Diabetes Meta-analysis finds small increased risk of retinopathy worsening after starting injectable semaglutide.
  Medscape Medical News, January 24, 2023
• AI Takes Root in Primary Care. First Stop: Diabetic Retinopathy Within seconds, artificial intelligence algorithms are diagnosing a complication of diabetes that can lead to blindness.
  Medscape Medical News, December 15, 2022
• Risks From Latent Autoimmune Diabetes in Adults Resemble Those for T2D The mortality and cardiovascular disease risks of people with latent autoimmune diabetes in adults was similar, but retinopathy risk higher, than those with type 2 diabetes in a Swedish study.
  First Look, December 14, 2022
• Treatment Type Doesn't Affect Risk of Retinal Detachment in DR Giving intravitreal injection only, or laser only, makes no difference to risk of later retinal detachment in patients with proliferative diabetic retinopathy, nor does 6-months plus loss to follow-up.
  Medscape Medical News, December 07, 2022
• UEG 2022 Type 1 Diabetes Complications Tied to Gut Microbiome Changes Alterations to composition and function of the gut microbiome have been identified in people with type 1 diabetes complications, with the greatest changes found in those with diabetic nephropathy.
  Medscape Medical News, October 09, 2022
• AAO 2022 With Approval Pending, Pegcetacoplan Phase 3 Results Mixed With an FDA action date set, investigative complement inhibitor pegcetacoplan showed a signal for improving visual function in geographic atrophy but also a risk for conversion to wet AMD.
  Medscape Medical News, October 03, 2022
• EASD 2022 Another Study Shows Fenofibrate Benefit on Diabetic Retinopathy While a Korean study shows reduction in diabetic retinopathy progression by 11% with fenofibrate plus statin compared with statin alone, some reservations remain over wider use.
  Medscape Medical News, September 23, 2022
• Type 1 Diabetes Complication Risk Rises With A1c, Duration Study following people for over 30 years from the time of type 1 diabetes diagnosis finds increasing risk of complications with A1c levels above a certain threshold, increasing duration of disease.
  Medscape Medical News, September 22, 2022